Methodological protocol demonstrates extrusion 3D bioprinting of human-scale cardiac patches using composite hydrogel bioinks, suggesting scalable manufacturing for heart failure therapies.
Extrusion-based bioprinting is a promising approach for developing novel clinical therapies for heart failure patients. Here, we present a protocol for bioprinting personalized human-scale cardiac patches incorporating human cardiac spheroids in a 1% silk fibroin/4% alginate/8% gelatin hydrogel. We describe steps for extrusion 3D bioprinting using a temperature-controlled hydrogel bioink. We also detail adjusting print parameters for optimal results. Although prepared for a specific experimental setup, the techniques described can be applied to other temperature-controlled biomaterials or extrusion 3D bioprinters. For complete details on the use and execution of this protocol, please refer to Roche et al., 1 , 2 Sharma et al., 3 and Vettori et al. 4
No takes yet. Share an insight, caveat, or question.
Matthews et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: